Multimodal treatment of resectable pancreatic ductal adenocarcinoma

Vincenzo Valentini, Francesco Cellini, Alessio Giuseppe Morganti, Vito Lorusso, Nicola Silvestris, Oronzo Brunetti, Enrico Vasile, Ivana Cataldo, Valeria Pusceddu, Monica Cattaneo, Stefano Partelli, Mario Scartozzi, Giuseppe Aprile, Andrea Casadei Gardini, Aldo Scarpa, Massimo Falconi, Angela Calabrese, Michele Reni, Stefano Cascinu

Risultato della ricerca: Contributo in rivistaArticolo in rivista

20 Citazioni (Scopus)

Abstract

After a timing preoperative staging, treatment of resectable pancreatic adenocarcinoma (PDAC) includes surgery and adjuvant therapies, the former representing the initial therapeutic option and the latter aiming to reduce the incidence of both distant metastases (chemotherapy) and locoregional failures (chemoradiotherapy). Herein, we provide a critical overview on the role of multimodal treatment in PDAC and on new opportunities related to current more active poli-chemotherapy regimens, targeted therapies, and the more recent immunotherapy approaches. Moreover, an analysis of pathological markers and clinical features able to help clinicians in the selection of the best therapeutic strategy will be discussed. Lastly, the role of neoadjuvant treatment of initially resectable disease will be considered mostly in patients whose malignancy shows morphological but not clinical or biological criteria of resectability. Depending on the results of these investigational studies, today a multidisciplinary approach can offer the best address therapy for these patients.
Lingua originaleEnglish
pagine (da-a)152-165
Numero di pagine14
RivistaCRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume111
DOI
Stato di pubblicazionePubblicato - 2017

Keywords

  • Adjuvant
  • Carcinoma, Pancreatic Ductal
  • Chemoradiotherapy
  • Chemotherapy
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Geriatrics and Gerontology
  • Hematology
  • Humans
  • Immunotherapy
  • Neoadjuvant Therapy
  • Oncology
  • Pancreatic Neoplasms
  • Pancreatic ductal adenocarcinoma
  • Radiotherapy
  • Randomized Controlled Trials as Topic
  • Target therapy

Fingerprint Entra nei temi di ricerca di 'Multimodal treatment of resectable pancreatic ductal adenocarcinoma'. Insieme formano una fingerprint unica.

Cita questo